Literature DB >> 22311343

Uric acid and IGF1 as possible determinants of FGF23 metabolism in children with normal renal function.

Justine Bacchetta1, Pierre Cochat, Isidro B Salusky, Katherine Wesseling-Perry.   

Abstract

BACKGROUND: Fibroblast growth factor 23 (FGF23) is a phosphaturic hormone and a suppressor of renal 1α hydroxylase. Although circulating values of FGF23 are increased in early chronic kidney disease (CKD), the interplay between FGF23 levels, growth and nutritional biomarkers has not been evaluated in children with normal renal function.
METHODS: We performed a secondary analysis of the cross-sectional observational INU23 study in 98 children (51 boys, mean age 10.5 ± 3.9 years) with preserved renal function (glomerular filtration rate (GFR) 114 ± 14 ml/min/1.73 m(2)).
RESULTS: In bivariate analyses, C-terminal FGF23 levels were positively related to phosphorus and uric acid levels. Intact FGF23 levels were positively associated with uric acid and insulin growth factor 1 (IGF1) levels, with similar results for age, body mass index (BMI), and 25OH vitamin D (25(OH)D). By multivariable analyses, 25(OH)D, uric acid, and phosphorus were independent predictors of C-terminal FGF23, while 25(OH)D, uric acid, and IGF1 were independent predictors of intact FGF23.
CONCLUSIONS: In children with preserved kidney function, the association between FGF23, uric acid, and IGF1 suggests that FGF23 could be an early nutritional indicator of high protein and phosphate intake. The association between FGF23 and IGF1 also suggests a relationship between FGF23 and growth, and warrants further investigation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22311343      PMCID: PMC3793329          DOI: 10.1007/s00467-012-2110-3

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  42 in total

Review 1.  Gout: excess calories, purines, and alcohol intake and beyond. Response to a urate-lowering diet.

Authors:  Adel G Fam
Journal:  J Rheumatol       Date:  2005-05       Impact factor: 4.666

2.  Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men.

Authors:  Diana M Antoniucci; Takeyoshi Yamashita; Anthony A Portale
Journal:  J Clin Endocrinol Metab       Date:  2006-05-30       Impact factor: 5.958

3.  Early skeletal and biochemical alterations in pediatric chronic kidney disease.

Authors:  Katherine Wesseling-Perry; Renata C Pereira; Chi-Hong Tseng; Robert Elashoff; Joshua J Zaritsky; Ora Yadin; Shobha Sahney; Barbara Gales; Harald Jüppner; Isidro B Salusky
Journal:  Clin J Am Soc Nephrol       Date:  2011-11-03       Impact factor: 8.237

4.  Mineralized tissue cells are a principal source of FGF23.

Authors:  Yuji Yoshiko; Hua Wang; Tomoko Minamizaki; Chise Ijuin; Ryoko Yamamoto; Setsuko Suemune; Katsuyuki Kozai; Kazuo Tanne; Jane E Aubin; Norihiko Maeda
Journal:  Bone       Date:  2007-02-08       Impact factor: 4.398

5.  Regulation of plasma fibroblast growth factor 23 by calcium in primary hyperparathyroidism.

Authors:  Keisuke Kobayashi; Yasuo Imanishi; Akimitsu Miyauchi; Naoyoshi Onoda; Takehisa Kawata; Hideki Tahara; Hitoshi Goto; Takami Miki; Eiji Ishimura; Toshitsugu Sugimoto; Tetsuro Ishikawa; Masaaki Inaba; Yoshiki Nishizawa
Journal:  Eur J Endocrinol       Date:  2006-01       Impact factor: 6.664

6.  Pretreatment serum FGF-23 levels predict the efficacy of calcitriol therapy in dialysis patients.

Authors:  Junichiro J Kazama; Fuminori Sato; Kentaro Omori; Hitomi Hama; Suguru Yamamoto; Hiroki Maruyama; Ichiei Narita; Fumitake Gejyo; Takeyoshi Yamashita; Seiji Fukumoto; Masafumi Fukagawa
Journal:  Kidney Int       Date:  2005-03       Impact factor: 10.612

7.  Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients.

Authors:  Shohei Nakanishi; Junichiro James Kazama; Tomoko Nii-Kono; Kentaro Omori; Takeyoshi Yamashita; Seiji Fukumoto; Fumitake Gejyo; Takashi Shigematsu; Masafumi Fukagawa
Journal:  Kidney Int       Date:  2005-03       Impact factor: 10.612

8.  Phenotypic and molecular genetic aspects of pseudohypoparathyroidism type Ib in a Greek kindred: evidence for enhanced uric acid excretion due to parathyroid hormone resistance.

Authors:  Elena Laspa; Murat Bastepe; Harald Jüppner; Agathocles Tsatsoulis
Journal:  J Clin Endocrinol Metab       Date:  2004-12       Impact factor: 5.958

Review 9.  How fibroblast growth factor 23 works.

Authors:  Shiguang Liu; L Darryl Quarles
Journal:  J Am Soc Nephrol       Date:  2007-05-09       Impact factor: 10.121

10.  Uric acid excretion in normal children.

Authors:  F B Stapleton; M A Linshaw; K Hassanein; A B Gruskin
Journal:  J Pediatr       Date:  1978-06       Impact factor: 4.406

View more
  11 in total

1.  Excessive fructose intake causes 1,25-(OH)(2)D(3)-dependent inhibition of intestinal and renal calcium transport in growing rats.

Authors:  Veronique Douard; Yves Sabbagh; Jacklyn Lee; Chirag Patel; Francis W Kemp; John D Bogden; Sheldon Lin; Ronaldo P Ferraris
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-04-09       Impact factor: 4.310

2.  Diabetes Complications in Childhood Diabetes-New Biomarkers and Technologies.

Authors:  Petter Bjornstad; David M Maahs
Journal:  Curr Pediatr Rep       Date:  2015-04-04

3.  Associations between fibroblast growth factor 23 and cardiac characteristics in pediatric heart failure.

Authors:  Tamara Isakova; Jessica Houston; Laura Santacruz; Eva Schiavenato; Gabriel Somarriba; William G Harmon; Steven E Lipshultz; Tracie L Miller; Paolo G Rusconi
Journal:  Pediatr Nephrol       Date:  2013-06-06       Impact factor: 3.714

4.  Association between serum uric acid and bone health in adolescents.

Authors:  F Karimi; M H Dabbaghmanesh; G R Omrani
Journal:  Osteoporos Int       Date:  2019-07-04       Impact factor: 4.507

5.  Insulin suppresses the production of fibroblast growth factor 23 (FGF23).

Authors:  Ludmilla Bär; Martina Feger; Abul Fajol; Lars-Oliver Klotz; Shufei Zeng; Florian Lang; Berthold Hocher; Michael Föller
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-14       Impact factor: 11.205

Review 6.  Chronic kidney disease: mineral and bone disorder in children.

Authors:  Katherine Wesseling-Perry; Isidro B Salusky
Journal:  Semin Nephrol       Date:  2013-03       Impact factor: 5.299

Review 7.  Bone fragility in patients with chronic kidney diseases.

Authors:  Martine Cohen-Solal; Thomas Funch-Brentano; Pablo Urena
Journal:  Endocr Connect       Date:  2020-03-01       Impact factor: 3.335

8.  Association between decreased klotho blood levels and organic growth hormone deficiency in children with growth impairment.

Authors:  Ido Wolf; Shiri Shahmoon; Michal Ben Ami; Yael Levy-Shraga; Kineret Mazor-Aronovitch; Orit Pinhas-Hamiel; Yonatan Yeshayahu; Rina Hemi; Hannah Kanety; Tami Rubinek; Dalit Modan-Moses
Journal:  PLoS One       Date:  2014-09-08       Impact factor: 3.240

9.  Examining the effects of uric acid-lowering on markers vascular of calcification and CKD-MBD; A post-hoc analysis of a randomized clinical trial.

Authors:  Emily S Andrews; Loni Perrenoud; Kristen L Nowak; Zhiying You; Andreas Pasch; Michel Chonchol; Jessica Kendrick; Diana Jalal
Journal:  PLoS One       Date:  2018-10-24       Impact factor: 3.240

Review 10.  Bone Fragility Fractures in CKD Patients.

Authors:  Ana Pimentel; Pablo Ureña-Torres; Jordi Bover; Jose Luis Fernandez-Martín; Martine Cohen-Solal
Journal:  Calcif Tissue Int       Date:  2020-11-21       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.